X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/17/2864264/0/en/Nxera-Pharma-Notice-of-Issuance-of-New-Shares-Under-the-Restricted-Stock-Unit-RSU-Plan-and-Determination-of-Payment-Amount-and-Other-Matters-of-Issuance-of-New-Shares-Under-Previou.html
https://www.globenewswire.com/news-release/2024/04/16/2863300/0/en/Nxera-Pharma-Notes-Successful-Development-Progress-of-Partnered-Schizophrenia-Candidate-NBI-1117568.html
https://www.biospectrumasia.com/news/25/24084/nxera-pharma-inks-deal-with-handok-to-distribute-pivlaz-in-south-korea.html
https://www.globenewswire.com/news-release/2024/04/14/2862478/0/en/Nxera-Pharma-Announces-Exclusive-Supply-and-Distribution-Agreement-with-Handok-for-PIVLAZ-in-South-Korea.html
https://www.globenewswire.com/news-release/2024/04/08/2859088/0/en/World-Orphan-Drug-Alliance-Expands-to-Japan-South-Korea-and-the-African-Subcontinent.html
https://www.globenewswire.com/news-release/2024/04/08/2858890/0/en/Nxera-Pharma-joins-the-World-Orphan-Drug-Alliance.html
https://www.globenewswire.com/news-release/2024/04/03/2856627/0/en/Nxera-Pharma-Appoints-Experienced-Senior-Strategy-Consultant-Patrick-Branch-as-Head-of-Business-Development-for-Japan-and-APAC.html
https://www.globenewswire.com/news-release/2024/03/31/2854969/0/en/Nxera-Pharma-is-the-New-Name-for-Sosei-Group.html
https://www.globenewswire.com/news-release/2024/03/21/2849874/0/en/Sosei-Heptares-Doses-First-Subject-in-Phase-1-Trial-with-HTL0033744-an-EP4-Agonist-for-Inflammatory-Bowel-Disease.html
https://www.globenewswire.com/news-release/2024/03/21/2849872/0/en/Sosei-Heptares-Regains-Full-Ownership-from-GSK-of-HTL0027477-a-Clinic-ready-First-in-Class-Oral-GPR35-Agonist-for-Inflammatory-Bowel-Disease.html
Market Place
Share 
